Literature DB >> 2869282

Interaction between methotrexate and non-steroidal anti-inflammatory drugs.

H Daly, J Boyle, C Roberts, G Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869282     DOI: 10.1016/s0140-6736(86)90910-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy.

Authors:  P J Wallis; K S Ryatt; T J Constable
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

3.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 4.  Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature.

Authors:  M G Ridley; C S Wolfe; J A Mathews
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

5.  Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 6.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 7.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

8.  Interaction between methotrexate and indomethacin on a human normal haemopoietic cell line.

Authors:  S J Hollingsworth; N P Shankley; E M Anderson; A Bennett
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

Review 9.  From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.

Authors:  Jackie Walling
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.651

10.  Biochemical and pharmacological consequences of the interaction between methotrexate and ketoprofen in the rabbit.

Authors:  A Perrin; G Milano; A Thyss; P Cambon; M Schneider
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.